{
    "clinical_study": {
        "@rank": "21638", 
        "arm_group": {
            "arm_group_label": "Chart review"
        }, 
        "brief_summary": {
            "textblock": "This study is conducted in the United States of America (USA). The aim of this study is to\n      assess the long-term (5+ years) postoperative functional outcomes of elective orthopaedic\n      surgery (EOS) patients from previously reported studies F7HAEM/USA/3/USA and\n      F7HAEM/USA/4/USA (NCT01561391) and furthermore to assess the impact of EOS on psychosocial\n      outcomes, frequency of bleeding episodes and durability of joint surgery."
        }, 
        "brief_title": "A Long-term Assessment of Physical Activity, Range of Motion, and Functional Status Following Elective Orthopedic Surgery in Hemophilia Patients With Inhibitors", 
        "completion_date": {
            "#text": "August 2011", 
            "@type": "Actual"
        }, 
        "condition": [
            "Congenital Bleeding Disorder", 
            "Haemophilia A With Inhibitors", 
            "Haemophilia B With Inhibitors"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Blood Coagulation Disorders", 
                "Hemostatic Disorders", 
                "Hemorrhagic Disorders", 
                "Hemophilia B", 
                "Hemophilia A", 
                "Hemorrhage"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Haemophilia patients with inhibitors who have had EOS during their participation in\n             F7HAEM/USA/3/USA and F7HAEM/USA/4/USA (NCT01561391)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Haemophilia patients with inhibitors who had EOS during their participation in\n        F7HAEM/USA/3/USA or F7HAEM/USA/4/USA (NCT01561391)."
            }
        }, 
        "enrollment": {
            "#text": "15", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "April 10, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01830712", 
            "org_study_id": "F7HAEM-3864", 
            "secondary_id": "U1111-1114-9206"
        }, 
        "intervention": {
            "arm_group_label": "Chart review", 
            "description": "A review of retrospectively longitudinal data gathered in the routine follow-up from a subset of patients who underwent EOS in studies F7HAEM/USA/3/USA and F7HAEM/USA/4/USA (NCT01561391). Data will be compiled, analysed, and reported in aggregate form.", 
            "intervention_name": "eptacog alfa (activated)", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Factor VIII"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "April 14, 2014", 
        "link": {
            "description": "Clinical Trials at Novo Nordisk", 
            "url": "http://novonordisk-trials.com"
        }, 
        "location": {
            "facility": {
                "address": {
                    "city": "Princeton", 
                    "country": "United States", 
                    "state": "New Jersey", 
                    "zip": "08540"
                }, 
                "name": "Novo Nordisk Clinical Trial Call Center"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "A Long-Term Assessment of Physical Activity, Range of Motion, and Functional Status Following Elective Orthopedic Surgery in Hemophilia Patients With Inhibitors. A Retrospective Follow-up Assessment to F7HAEM/USA/3/USA and F7HAEM/USA/4/USA", 
        "overall_official": {
            "affiliation": "Novo Nordisk A/S", 
            "last_name": "Global Clinical Registry (GCR, 1452)", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Long-term changes in general mobility/ambulation/activity", 
            "safety_issue": "No", 
            "time_frame": "From pre-operative (baseline) functional status and up to at least 5 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01830712"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Long-term changes in work/school attendance", 
                "safety_issue": "No", 
                "time_frame": "From pre-operative (baseline) functional status and up to at least 5 years"
            }, 
            {
                "measure": "Long-term changes in employment status", 
                "safety_issue": "No", 
                "time_frame": "From pre-operative (baseline) functional status and up to at least 5 years"
            }, 
            {
                "measure": "Long-term changes in body mass index (BMI)", 
                "safety_issue": "No", 
                "time_frame": "From pre-operative (baseline) functional status and up to at least 5 years"
            }, 
            {
                "measure": "Long-term changes in complications related to surgical procedure and/or prostheses", 
                "safety_issue": "No", 
                "time_frame": "From pre-operative (baseline) functional status and up to at least 5 years"
            }, 
            {
                "measure": "Overall frequency of bleeding episodes", 
                "safety_issue": "No", 
                "time_frame": "From pre-operative (baseline) functional status and up to at least 5 years"
            }, 
            {
                "measure": "Number of joint infections", 
                "safety_issue": "No", 
                "time_frame": "From pre-operative (baseline) functional status and up to at least 5 years"
            }, 
            {
                "measure": "Number of treatment types (on demand, prophylaxis)", 
                "safety_issue": "No", 
                "time_frame": "From pre-operative (baseline) functional status and up to at least 5 years"
            }
        ], 
        "source": "Novo Nordisk A/S", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Novo Nordisk A/S", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "April 2011", 
        "study_design": "Observational Model: Cohort, Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "April 2014"
    }
}